Omiganan

DRUG5 trials

Sponsors

Maruho Co., Ltd.

Conditions

Atopic DermatitisHealthyPapulopustular RosaceaRosaceaSeborrheic Dermatitis

Phase 1

Topical Challenge With Omiganan and Imiquimod in Healthy Volunteers

CompletedNCT03071679

Maruho Co., Ltd.Healthy

Start: 2017-02-06End: 2017-03-07Updated: 2017-05-22

Phase 2

A Twelve Week Safety and Efficacy Study in Rosacea

CompletedNCT01784133

Maruho Co., Ltd.Papulopustular Rosacea

Start: 2013-03-31Updated: 2015-05-20

Pharmacodynamics of Omiganan BID in Patients With Atopic Dermatitis

CompletedNCT03091426

Maruho Co., Ltd.Atopic Dermatitis

Start: 2017-03-08End: 2017-12-20Updated: 2017-12-27

Omiganan Twice a Day (BID) in Patients With Facial Seborrheic Dermatitis

Maruho Co., Ltd.Seborrheic Dermatitis

Start: 2018-10-22End: 2019-12-31Target: 36Updated: 2019-05-01

Phase 3

Study to Evaluate the Long-term Safety of a Once-Daily Omiganan Topical Gel

CompletedNCT02576847

Maruho Co., Ltd.Rosacea

Start: 2015-10-31End: 2018-02-08Updated: 2022-07-19

Related Papers

Rational design of stapled antimicrobial peptides.

2023-02-1228 citations